𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Consolidation therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of cytosine arabinoside, epipodophyllotoxins and cyclophosphamide

✍ Scribed by E.J. Estlin; S.M. Yule; S.P. Lowis

Book ID
117817316
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
193 KB
Volume
27
Category
Article
ISSN
0305-7372

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The treatment of acute lymphoblastic leu
The treatment of acute lymphoblastic leukaemia (ALL) in childhood, Ukall III: The effects of added cytosine arabinoside and/or asparaginase, and a comparison of continuous or discontinuous mercaptopurine in regimens for standard risk ALL
✍ Rothwell, Miss D. πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 439 KB

## Abstract In a comparison of treatments for standard‐risk acute lymphoblastic leukaemia in children (UKALL III), there were no differences in remission lengths between regimens with or without second‐line drugs (cytosine arabinoside and asparaginase) and with continuous or discontinuous mercaptop

A pilot study of intermediate-dose metho
A pilot study of intermediate-dose methotrexate and cytosine arabinoside, β€œSpread-out” or β€œUp-front,” in continuation therapy for childhood non-T, non-B acute lymphoblastic leukemia a pediatric oncology group study
✍ Robert A. Krance; Edward M. Newman; Donald Pinkel; Yaddanapudi Ravindranath; Mic πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 723 KB

One hundred six children with newly diagnosed non-T-, non-B-cell acute lymphoblastic leukemia (ALL) were treated in a Pediatric Oncology Group (POG) pilot study in which six courses of intermediate-dose methotrexate (MTX) and cytosine arabinoside (Ara-C) (1 g/m2 each) were added to a "backbone" of s